Mechanistically, HIF-2α promotes HCC proliferation, migration, and invasion through the HIF-2α/VEGF/Notch1 signaling axis, indicating that HIF-2α may serve as a potential target for preventing HCC recurrence and progression following IRFA. Here, EPAS1 is linked to hepatocellular carcinoma.